Tag: nasdaq:agio
April 7, 2021
5 Top Biotechnology ETFs
For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
January 26, 2021
Top Life Science ETFs of 2020
What are the top life science ETFs? Here's a look at the five best-performing life science ETFs of 2020. November 13, 2019
Agios Pharmaceuticals Closes Public Offering
The company has additionally announced the option for its underwriters to purchase an additional 1.23 million shares at US$31 each.
January 1, 2019
An Investor’s Guide to Clinical Trials
Clinical trials can be one of the more challenging US Food and Drug Administration processes to understand, but grasping the... December 3, 2018
Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial
Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented... November 16, 2018
Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
Agios Pharmaceuticals (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented...
October 2, 2018